![Immunotherapy in the media [Infographic]](https://commetric.com/wp-content/uploads/2022/05/Immunotherapy.jpg)
by Commetric | May 24, 2022 | Blog
Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople,...
by Commetric | May 20, 2022 | Blog
The global sustainability movement has grown in power and force in recent years, but alongside that rapid ascent has come an equally booming side effect – corporate greenwashing. Our analysis found that the use of the term “greenwashing” has been steadily...
by Commetric | May 13, 2022 | Blog
As pharma experiences continued momentum for immuno-oncology treatments, with the current drug development pipeline consisting of thousands of potential therapies and therapy combinations, the media conversation around immuno-oncology is becoming livelier and...
by Commetric | May 9, 2022 | Newsroom
We are thrilled to announce that our work with Novartis was distinguished in two categories at the DataComms Awards 2022. Our entry, “Integrated multichannel measurement for World Sight Day and XOVA”, won Gold in the Best use of data as part of an...
by Commetric | Apr 29, 2022 | Blog
Elon Musk’s $44bn deal to buy Twitter might as well be the most widely commented business event of the past few years, as critics and supporters were quick to weigh in on what could lie ahead. Our media analysis showed that many commentators are divided on the...
